Literature DB >> 18941180

Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses.

Irina Puliaeva1, Roman Puliaev, Andrei Shustov, Mark Haas, Charles S Via.   

Abstract

Fas-mediated apoptosis is an important contributor to contraction of Ag-driven T cell responses acting only on activated Ag-specific T cells. The effects of targeted Fas deletion on selected cell populations are well described however little is known regarding the consequences of Fas deletion on only activated Ag-specific T cells. We addressed this question using the parent-into-F(1) (P-->F(1)) model of acute or chronic (lupus-like) graft-vs-host disease (GVHD) as a model of either a CTL-mediated or T-dependent B cell-mediated response, respectively. By transferring Fas-deficient lpr donor T cells into Fas-intact F(1) hosts, the in vivo role of Ag-specific T cell Fas can be determined. Our results demonstrate a novel dichotomy of Ag-specific T cell Fas function in that: 1) Fas expression on Ag-activated T cells has costimulatory, helper, and down-regulatory roles in vivo and 2) these roles were observed only in a CTL response (acute GVHD) and not in a T-dependent B cell response (chronic GVHD). Specifically, CD4 T cell Fas expression is important for optimal CD4 initial expansion and absolutely required for help for CD8 effector CTL. Donor CD8 T cell Fas expression played an important but not exclusive role in apoptosis and down-regulation. By contrast, CD4 Fas expression played no detectable role in modulating chronic GVHD induction or disease expression. These results demonstrate a novel role for Ag-specific T cell Fas expression in in vivo CTL responses and support a review of the paradigm by which Fas deficiency accelerates lupus in MRL/lpr lupus-prone mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941180      PMCID: PMC2775525          DOI: 10.4049/jimmunol.181.9.5912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  101 in total

Review 1.  The role of cytotoxicity in lymphocyte homeostasis.

Authors:  G de Saint Basile; A Fischer
Journal:  Curr Opin Immunol       Date:  2001-10       Impact factor: 7.486

Review 2.  The chronic graft-versus-host model of systemic autoimmunity.

Authors:  Robert Eisenberg
Journal:  Curr Dir Autoimmun       Date:  2003

3.  A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Subash Sad; Hao Shen; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

4.  Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells.

Authors:  D Watanabe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1995-12       Impact factor: 4.823

5.  The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells.

Authors:  I Suzuki; P J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens.

Authors:  L Van Parijs; D A Peterson; A K Abbas
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

7.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.

Authors:  D Balomenos; R Rumold; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

8.  Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease.

Authors:  Roman Puliaev; Phuong Nguyen; Fred D Finkelman; Charles S Via
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 9.  The role of CD95 in the regulation of peripheral T-cell apoptosis.

Authors:  Andreas Krueger; Stefanie C Fas; Sven Baumann; Peter H Krammer
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

10.  CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.

Authors:  J C Rathmell; M P Cooke; W Y Ho; J Grein; S E Townsend; M M Davis; C C Goodnow
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

View more
  14 in total

1.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

2.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

Review 3.  Advances in lupus stemming from the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Trends Immunol       Date:  2010-03-31       Impact factor: 16.687

Review 4.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

Review 5.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

6.  B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.

Authors:  Kateryna Soloviova; Irina Puliaeva; Maksym Puliaiev; Roman Puliaev; Charles S Via
Journal:  Cell Immunol       Date:  2020-05-05       Impact factor: 4.868

7.  Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.

Authors:  Irina Puliaeva; Kateryna Soloviova; Maksym Puliaiev; Thomas Lang; Roman Puliaev; Charles S Via
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

8.  Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Authors:  Charles S Via; Gene M Shearer
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

9.  In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Charles S Via
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

10.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.